–
Caribou Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−67.0
FY22:
−106
FY23:
−116
FY24:
−167
FY25:
−148
(positive)
Change from FY21 to FY24
millions USD
FY21:
−67.6
FY22:
−105
FY23:
−113
FY24:
−163
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.6
FY22:
−99.4
FY23:
−102
FY24:
−149
FY25:
−149
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.9
FY22:
−99.4
FY23:
−102
FY24:
−149
FY25:
−148
All amounts in millions USD